{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:28:10Z","timestamp":1726511290219},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thesurgeon.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Surgeon"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.surge.2013.11.021","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T06:30:36Z","timestamp":1389249036000},"page":"61-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma"],"prefix":"10.1016","volume":"13","author":[{"given":"D.M.","family":"Layfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Odofin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.T.","family":"Royle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.I.","family":"Cutress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surge.2013.11.021_bib1","unstructured":"The second all breast cancer report. The National Cancer Intelligence Network, Published 08\/06\/2011. Available at: http:\/\/www.ncin.org.uk\/search\/all+breast+cancer+report.aspx [accessed 28.06.13]."},{"key":"10.1016\/j.surge.2013.11.021_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1308\/003588413X13629960045832","article-title":"A UK national survey of breast surgeons on primary endocrine therapy of early operable breast cancer","volume":"95","author":"Wylie","year":"2013","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.surge.2013.11.021_bib3","unstructured":"National Institute for Health and Clinical Excellence Guidelines. CG80 \u2013 Early and locally advanced breast cancer: diagnosis and treatment. Issued February 2009. Available at: http:\/\/publications.nice.org.uk\/early-and-locally-advanced-breast-cancer-cg80. [accessed 18.12.11]."},{"key":"10.1016\/j.surge.2013.11.021_bib4","first-page":"CD004272","article-title":"Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)","volume":"25","author":"Hind","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.surge.2013.11.021_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.4603","article-title":"Randomised trial of surgery plus tamoxifen versus tamoxifen alone in women over 70 with operable breast cancer","volume":"91","author":"Fennessey","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.surge.2013.11.021_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/annonc\/mdg117","article-title":"Tamoxifen alone verses adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomised controlled multicentre GRETA trial","volume":"14","author":"Mustacchi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0960-9776(97)90557-9","article-title":"Investigation of primary tamoxifen therapy for elderly patients with operable breast cancer","volume":"6","author":"Willsher","year":"1997","journal-title":"Breast"},{"key":"10.1016\/j.surge.2013.11.021_bib8","first-page":"207","article-title":"Prospective randomised trial of tamoxifen verses surgery in elderly patients with breast cancer","volume":"20","author":"Gazet","year":"1994","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0960-9776(98)90077-7","article-title":"Long-term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer","volume":"7","author":"Kenny","year":"1998","journal-title":"Breast"},{"key":"10.1016\/j.surge.2013.11.021_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0959-8049(02)00673-1","article-title":"Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy","volume":"39","author":"Fentiman","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surge.2013.11.021_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1245\/s10434-011-2070-z","article-title":"Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer","volume":"19","author":"Wink","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2009.01.035","article-title":"Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicentre phase II trial","volume":"208","author":"Olson","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surge.2013.11.021_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00280-008-0735-5","article-title":"Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal women with hormone receptor-positive breast cancer","volume":"63","author":"Seo","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.surge.2013.11.021_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.breast.2009.09.012","article-title":"Neoadjuvant endocrine treatment in primary breast cancer \u2013 review of literature","volume":"18","author":"Mathew","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.surge.2013.11.021_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.surge.2013.11.021_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0959-8049(99)00319-6","article-title":"Measuring comorbidity in older cancer patients","volume":"36","author":"Extermann","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surge.2013.11.021_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.surge.2013.11.021_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cQuickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Detre","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.surge.2013.11.021_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1988.315","article-title":"Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer","volume":"58","author":"Nicholson","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surge.2013.11.021_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jnci\/88.11.716","article-title":"Factors associated with surgical and radiation therapy for early stage breast cancer in older women","volume":"88","author":"Ballard-Barash","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.surge.2013.11.021_bib21","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1200\/JCO.2011.35.5545","article-title":"Influence of comorbidities and age on the risk of death without recurrence: a retrospective analysis of the arimidex, tamoxifen alone or in combination trial","volume":"29","author":"Ring","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib22","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","article-title":"Breast cancer among the oldest old: tumour characteristics, treatment choices and survival","volume":"28","author":"Schonberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib23","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1639","article-title":"Hormone receptor status, tumour characteristics and prognosis: a prospective cohort of breast cancer patients","volume":"9","author":"Dunnwald","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.surge.2013.11.021_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","article-title":"Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older","volume":"285","author":"Yancik","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.surge.2013.11.021_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-120-2-199401150-00002","article-title":"The effect of comorbidity on 3-year survival of women with primary breast cancer","volume":"15","author":"Satariano","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.surge.2013.11.021_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trails of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003370.pub3","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","author":"Gibson","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.surge.2013.11.021_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.4603","article-title":"Late follow-up of a randomized trial of surgery plus tamoxifen versus tamofifen alone in women aged over 70 years with operable breast cancer","volume":"91","author":"Fennessy","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.surge.2013.11.021_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/bjc.1989.256","article-title":"Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer","volume":"60","author":"Anderson","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surge.2013.11.021_bib30","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2001.19.18.3808","article-title":"Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1 and\/or ErbB-2 positive, oestrogen receptor-positive primary breast cancer: evidence from a phase III randomised trial","volume":"19","author":"Ellis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surge.2013.11.021_bib31","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/jnci\/djn309","article-title":"Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumour characteristics","volume":"100","author":"Ellis","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.surge.2013.11.021_bib32","first-page":"397","article-title":"Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer","volume":"25","author":"Ying","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.surge.2013.11.021_bib33","doi-asserted-by":"crossref","first-page":"951s","DOI":"10.1158\/1078-0432.951s.11.2","article-title":"Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival","volume":"11","author":"Dowsett","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surge.2013.11.021_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-007-9700-y","article-title":"Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98","volume":"105","author":"Koeberle","year":"2007","journal-title":"Breast Cancer Res Treat"}],"container-title":["The Surgeon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X13001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X13001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:40:47Z","timestamp":1688917247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1479666X13001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1479666X13001650"],"URL":"https:\/\/doi.org\/10.1016\/j.surge.2013.11.021","relation":{},"ISSN":["1479-666X"],"issn-type":[{"type":"print","value":"1479-666X"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma","name":"articletitle","label":"Article Title"},{"value":"The Surgeon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surge.2013.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}